title: ProC global: a new automated screening assay for the evaluation of total function of the protein C system.
abstract: Protein C (PC) pathway represents a major physiologic inhibitory mechanism regulating the coagulation cascade. A new automated functional screening assay (ProC Global) for the evaluation of the PC-system was tested to define its ability to identify patients with known inherited defects such as factor V (FV) Leiden mutation and PC and protein S (PS) deficiency. A total of 249 patients who were symptomatic or asymptomatic for previous venous thromboembolism (VTE) were evaluated, 50 of whom had FV Leiden mutation, 36 had PC deficiency, and 34 had PS deficiency. One hundred healthy subjects were also tested, as well as 40 blood donors of both sexes in whom coagulation abnormalities were not found. Results of ProC Global test were expressed as normalized ratio (NR) and values below an established cut-off level were consistent with a positive test. ProC Global was positive in all 50 patients with the FV Leiden mutation (mean NR = 0.59; range, 0.37 to 0.69). ProC Global correctly identified 32 of 36 (89%) PC defects (mean NR = 0.63; range, 0.34 to 1.21) and 25 of 34 (73.5%) PS defects (mean NR = 0.76; range, 0.5 to 1.23). Overall, 92.5% of hereditary defects of the PC system considered in this study were identified by ProC Global test. ProC Global exhibited NR above cut-off level in all 40 blood donors without coagulation defects. ProC Global is a new automated screening test with some diagnostic potential in identifying patients with defects of the PC system. However, ProC Global in its current form cannot substitute the assay of each single component of this inhibitory system in the daily screening for thrombophilia.
authors.affiliation: Thrombosis Center, Department of Biotecnologie Cellulari ed Ematologia, University La Sapienza, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Dragoni
authors.forename: D
authors.initials: D
authors.lastname: Tormene
authors.forename: P
authors.initials: P
authors.lastname: Simioni
authors.forename: P
authors.initials: P
authors.lastname: Arcieri
authors.forename: G
authors.initials: G
authors.lastname: Avvisati
authors.forename: A
authors.initials: A
authors.lastname: Girolami
mesh_terms: D000293:Adolescent; D000328:Adult; D001796:Blood Protein Disorders / Q000175:diagnosis*; D016022:Case-Control Studies; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000032:analysis* / Q000378:metabolism; D011933:Reagent Kits, Diagnostic / Q000592:standards*; D012015:Reference Standards; D015203:Reproducibility of Results; D013923:Thromboembolism / Q000097:blood; D019851:Thrombophilia / Q000097:blood / Q000175:diagnosis; D020246:Venous Thrombosis / Q000097:blood
chemical_list: D011486:Protein C; D011933:Reagent Kits, Diagnostic